Precision BioSciences, Inc. logo

Precision BioSciences, Inc.

NASDAQ:DTIL

Overview | Financials
Company Name Precision BioSciences, Inc.
Symbol DTIL
Currency USD
Price 5.33
Market Cap 55,868,687
Dividend Yield 0%
52-week-range 3.61 - 13.436
Industry Biotechnology
Sector Healthcare
CEO Mr. Michael Amoroso
Website https://www.precisionbiosciences.com

An error occurred while fetching data.

About Precision BioSciences, Inc.

Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy

Related Stocks

Forian Inc. logo

Forian Inc.

FORA

1.97 USD

Passage Bio, Inc. logo

Passage Bio, Inc.

PASG

0.322 USD

NextCure, Inc. logo

NextCure, Inc.

NXTC

0.46 USD

Taysha Gene Therapies, Inc. logo

Taysha Gene Therapies, Inc.

TSHA

1.76 USD

Financials

Numbers are in millions USD

Numbers are in millions USD